Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for Opioid Use Reduction in Hysterectomy
NCT06039566Phase 3Completed
- Sponsor
- Medical University of South Carolina
- Start
- Nov 2023
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in postoperative pain comparing IV Placebo with IV N-acetylcysteine (2 arms). Primary endpoint: Opioid Consumption 0-72 hours post-study medication. Started Nov 2023; status: completed.
02
Drugs
acetylcysteine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06039566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06039566.